Condition: Psychosis Associated With Alzheimer's Disease · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Alzheimer's Disease. The primary objective of the study is to evaluate relapse prevention in subjects with psychosis associated with Alzheimer's Disease treated with KarXT compared to placebo. The secondary objectives of the study are to evaluate the time from randomization to discontinuation for any reason or relapse and safety and tolerability in subjects with psychosis associated with Alzheimer's Disease treated with KarXT compared to placebo.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 1029 | Homewood, Alabama, United States | Active Not Recruiting |
| Local Institution - 1044 | Phoenix, Arizona, United States | Completed |
| Local Institution - 1033 | Encino, California, United States | Completed |
| Local Institution - 1031 | Irvine, California, United States | Withdrawn |
| ATP Clinical Research-302 W La Veta Ave | Orange, California, United States | Recruiting |
| Local Institution - 1043 | Pasadena, California, United States | Completed |
| Local Institution - 1047 | San Marcos, California, United States | Completed |
| Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS | Walnut Creek, California, United States | Recruiting |
| Local Institution - 1014 | Colorado Springs, Colorado, United States | Completed |
| Local Institution - 1013 | Stamford, Connecticut, United States | Completed |
| Local Institution - 1011 | Boca Raton, Florida, United States | Completed |
| Local Institution - 1020 | Bonita Springs, Florida, United States | Completed |
+ 117 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05511363